Deborah J Ossip1, Zahíra Quiñones2, Sergio Diaz3, Kelly Thevenet-Morrison1, Susan Fisher4, Heather Holderness1, Xeuya Cai5, Scott McIntosh1, Ann Dozier1, Nancy Chin1, Emily Weber1, Jose Javier Sanchez2, Arisleyda Bautista6, Almonte Héctor7. 1. Department of Public Health Sciences, University of Rochester Medical Center, Rochester, NY, USA. 2. Pontificia Universidad Católica Madre y Maestra, Santiago, Dominican Republic. 3. Pontificia Universidad Católica Madre y Maestra, Santiago, Dominican Republic; Hospital Regional Universitario José Maria Cabral y Baez, Santiago, Dominican Republic. 4. Department of Clinical Sciences, Temple University School of Medicine, Philadelphia, PA, USA. 5. Department of Biostatistics, University of Rochester Medical Center, Rochester, NY, USA. 6. Centro de Atención Primaria Juan XXIII, Santiago, Dominican Republic. 7. Private Practice, Santiago, Dominican Republic.
Abstract
INTRODUCTION: Tobacco use and harm continue to increase in low- and middle income countries (LMICs) globally. Smoking cessation is the most effective means of reducing morbidity and mortality from tobacco use. Increasing the prevalence of ex-users is an indicator of population cessation. AIMS: This study provides the first examination of factors associated with ex-tobacco use status in the Dominican Republic (DR), a LMIC in the Latin America and Caribbean region. METHODS: Baseline surveillance was conducted for 1177 randomly selected households in 7 economically disadvantaged DR communities (total N=2680 adult household members). RESULTS: Ex-user prevalence was 10.6% (1.0%-18.5% across communities), 14.8% were current users (9.1-20.4), and quit ratios were 41.7% (9.7%-52.7%). Among ever-users, females (OR 2.02, 95% CI 1.41, 2.90), older adults (45-64: OR 1.75, 95% CI 1.12, 2.74; 65+: OR 2.09, 95% CI 1.29, 3.39), and those who could read/write (OR 1.64, 95% CI 1.08, 2.50), had health conditions (OR 1.63, 95% CI 1.11, 2.41), and lived with ex-users (OR 1.70, 95% CI 1.12, 2.58) were over 60% to two times as likely to be ex-users. Those from remote communities (OR 0.52, 95% CI 0.36, 0.74), using chewed tobacco (OR 0.14, 95% CI 0.04, 0.48) and living with tobacco users (OR 0.55, 95% CI 0.37, 0.81) were less likely to be ex-users. CONCLUSIONS: Ex-user prevalence and quit ratios were lower than for high income countries. Implementing broad tobacco control measures, combined with clinically targeting vulnerable groups, may increase tobacco cessation to most effectively reduce this public health crisis.
INTRODUCTION:Tobacco use and harm continue to increase in low- and middle income countries (LMICs) globally. Smoking cessation is the most effective means of reducing morbidity and mortality from tobacco use. Increasing the prevalence of ex-users is an indicator of population cessation. AIMS: This study provides the first examination of factors associated with ex-tobacco use status in the Dominican Republic (DR), a LMIC in the Latin America and Caribbean region. METHODS: Baseline surveillance was conducted for 1177 randomly selected households in 7 economically disadvantaged DR communities (total N=2680 adult household members). RESULTS: Ex-user prevalence was 10.6% (1.0%-18.5% across communities), 14.8% were current users (9.1-20.4), and quit ratios were 41.7% (9.7%-52.7%). Among ever-users, females (OR 2.02, 95% CI 1.41, 2.90), older adults (45-64: OR 1.75, 95% CI 1.12, 2.74; 65+: OR 2.09, 95% CI 1.29, 3.39), and those who could read/write (OR 1.64, 95% CI 1.08, 2.50), had health conditions (OR 1.63, 95% CI 1.11, 2.41), and lived with ex-users (OR 1.70, 95% CI 1.12, 2.58) were over 60% to two times as likely to be ex-users. Those from remote communities (OR 0.52, 95% CI 0.36, 0.74), using chewed tobacco (OR 0.14, 95% CI 0.04, 0.48) and living with tobacco users (OR 0.55, 95% CI 0.37, 0.81) were less likely to be ex-users. CONCLUSIONS: Ex-user prevalence and quit ratios were lower than for high income countries. Implementing broad tobacco control measures, combined with clinically targeting vulnerable groups, may increase tobacco cessation to most effectively reduce this public health crisis.
Authors: Harry A Lando; Bethany J Hipple; Myra Muramoto; Jonathan D Klein; Alexander V Prokhorov; Deborah J Ossip; Jonathan P Winickoff Journal: Bull World Health Organ Date: 2010-01 Impact factor: 9.408
Authors: A M Dozier; D J Ossip-Klein; S Diaz; N P Chin; E Sierra; Z Quiñones; T D Dye; S McIntosh; L Armstrong Journal: Tob Control Date: 2006-06 Impact factor: 7.552
Authors: Essie T Torres; Joseph Guido; Zahira Quiñones de Monegro; Sergio Diaz; Ann M Dozier; Scott McInstosh; Deborah J Ossip Journal: Matern Child Health J Date: 2014-12
Authors: Gary A Giovino; Sara A Mirza; Jonathan M Samet; Prakash C Gupta; Martin J Jarvis; Neeraj Bhala; Richard Peto; Witold Zatonski; Jason Hsia; Jeremy Morton; Krishna M Palipudi; Samira Asma Journal: Lancet Date: 2012-08-18 Impact factor: 79.321